Endocrine Research
CJC-1295 (No DAC) + Ipamorelin
29 + 5 amino acids · 3367.9 / 711.9 g/mol
WADA: prohibitedView
Sequence, molecular data, research status and testing standards for GHRP-2, written for Canadian researchers.
GHRP-2 (growth hormone-releasing peptide 2) is a synthetic six-amino-acid peptide that activates the ghrelin receptor. It is a more potent relative of GHRP-6.
GHRP-2 has been used in research on the growth hormone axis. In Japan, the compound pralmorelin has been used as a diagnostic agent to test the pituitary's ability to release growth hormone. It is not authorized in Canada.
What it isA lab-made chain that copies the hunger hormone ghrelin.
The plain-English storyGhrelin is the hunger hormone, and one of its side jobs is telling your master gland to release growth hormone. GHRP-2 is a lab-made lookalike that does the same. It has been used in research, and in Japan as a diagnostic test. It is not an approved medicine here and is banned in sport.
How it works, in simple termsIt tells the body's master gland to release growth hormone.
What the science really showsUsed in research, and as a diagnostic test in Japan.
Where it stands in CanadaNot an approved medicine in Canada, so nobody can legally sell it to you as one. Also banned in sport.
Educational information only. Not medical advice, and not a claim that this peptide is safe or effective for any use.
Peptide Authority summarizes published research for educational purposes only. Nothing here is medical advice or a claim that GHRP-2 is safe or effective for any use.
| Type | Status in Canada | |
|---|---|---|
| GHRP-2 | Hexapeptide ghrelin-receptor agonist | Research compound |
| GHRP-6 | Hexapeptide ghrelin-receptor agonist | Research compound |
| Ipamorelin | Pentapeptide ghrelin-receptor agonist | Research compound |
See the GHRP-6 and ipamorelin profiles.
GHRP-2 is not authorized by Health Canada as a drug, so it cannot legally be sold for human or animal use in Canada. This is general information, not legal advice. Peptide Authority does not sell GHRP-2. Read how peptides are regulated in Canada.
GHRP-2 (growth hormone-releasing peptide 2) is a synthetic six-amino-acid peptide that activates the ghrelin receptor. It is a more potent relative of GHRP-6. It is also known as Pralmorelin, KP-102.
GHRP-2 is not authorized by Health Canada as a drug, so it cannot legally be sold for human or animal use in Canada. This is general information, not legal advice. Peptide Authority does not sell GHRP-2.
Peptide Authority does not sell GHRP-2. It is not authorized for human or animal use in Canada, and products sold online cannot be verified without a lot-matched third-party Certificate of Analysis.
Both are hexapeptides acting on the ghrelin receptor. GHRP-2 is generally described as more potent at stimulating growth hormone release, while GHRP-6 is the original compound and has a stronger effect on appetite signalling.
Yes. GHRP-2 is on the World Anti-Doping Agency (WADA) Prohibited List: Prohibited: S2 (growth hormone-releasing peptides).
29 + 5 amino acids · 3367.9 / 711.9 g/mol
29 amino acids (modified) · 3647.2 g/mol
This profile is for information only and is not medical advice. Products sold by Peptide Authority are for in-vitro laboratory research only and are not for human or animal consumption. See our full disclaimer.